Therapy and Trending Topics
Postpartum Depression
Premenstrual Dysphoric Disorder
Integrative Psychiatry
Hormones
Hair Loss
Depression
Anxiety
Dual-certified Nurse Practitioner Specializing in Women’s Mental Health and Wellness.
Modafinil is a prescription wakefulness-promoting medicine that has been studied extensively in
clinical pharmacology and sleep medicine. Its principal medical relevance is connected with
conditions in which excessive daytime sleepiness becomes a persistent clinical symptom. You may get Modalert 200 mg with prescription from our Doctors
The compound has attracted scientific attention because its pharmacological profile differs from
that of several older stimulant medicines. Research has examined how modafinil interacts with
neurotransmitter transporters, influences neural arousal networks, and affects measurable aspects
of wakefulness.
Modern research also considers modafinil within the broader framework of sleep physiology. The
relationship between circadian rhythms, homeostatic sleep pressure, neurotransmission, and daytime
alertness helps explain why excessive sleepiness can occur and why its treatment requires a clinical
context.
Sleep medicine focuses on disorders that alter normal patterns of sleep, wakefulness, breathing,
or circadian timing. Excessive daytime sleepiness is one of the most important symptoms evaluated
in this field.
Ordinary tiredness can result from temporary sleep loss, physical activity, stress, or other
short-term circumstances. Excessive daytime sleepiness associated with a sleep disorder represents
a different physiological problem and can persist despite apparently adequate opportunities for
sleep.
Evaluation of excessive sleepiness may involve medical history, sleep diaries, standardized
questionnaires, and laboratory sleep studies. Identifying the underlying disorder is an important
part of treatment planning.
Modafinil is a chiral pharmaceutical compound, meaning that its molecular structure can exist in
two different mirror-image configurations.
The two stereochemical forms are referred to as R-modafinil and S-modafinil. Their three-dimensional
structures are different even though they share the same molecular formula.
Stereochemistry can influence the interaction of pharmaceutical molecules with transporters,
enzymes, and receptors. For this reason, individual enantiomers are frequently investigated during
drug development.
The biological effects of modafinil are complex and cannot be explained by a single physiological
process.
A well-established molecular action of modafinil is its interaction with the dopamine transporter.
This interaction reduces dopamine reuptake and changes extracellular dopamine signaling.
Wakefulness depends on interconnected neural pathways rather than one isolated neurotransmitter.
Dopaminergic signaling interacts with noradrenergic, histaminergic, cholinergic, and orexin-related
systems.
Orexin neurons help stabilize wakefulness and regulate transitions between sleep and alertness.
This system is particularly relevant to the biology of narcolepsy.
Normal alertness is determined by the interaction of two major processes: circadian timing and
homeostatic sleep pressure.
The circadian system generates approximately 24-hour biological rhythms and coordinates the timing
of sleep and wakefulness.
Homeostatic sleep pressure accumulates during periods of wakefulness and decreases during sleep.
It provides a mechanism for balancing the need to remain awake with the physiological need for
sleep.
Circadian timing and sleep pressure continuously interact. Disruption of either system can
contribute to excessive sleepiness or difficulty maintaining normal alertness.
Narcolepsy is a neurological sleep disorder characterized by excessive daytime sleepiness and
abnormal sleep-wake regulation.
Modafinil has been studied extensively in patients with narcolepsy. Clinical research has included
both subjective assessments of sleepiness and objective measures of the ability to remain awake.
Laboratory methods can provide quantitative measurements of sleep propensity and wakefulness.
These assessments are useful when evaluating the effects of treatment under controlled conditions.
Obstructive sleep apnea is a sleep-related breathing disorder in which repeated upper-airway
obstruction disrupts normal sleep.
Repeated breathing disturbances can fragment sleep and contribute to daytime impairment. Some
patients continue to experience excessive sleepiness even when the underlying breathing disorder
is being managed.
Modafinil has an established clinical role in certain patients with excessive sleepiness associated
with obstructive sleep apnea. Its purpose in this context is related to wakefulness rather than
correction of the airway obstruction itself.
Shift work can place waking and sleeping periods at times that conflict with the body’s natural
circadian rhythm.
The biological clock normally promotes sleepiness during part of the night. Working during this
period can therefore create substantial challenges for maintaining alertness.
Modafinil has been investigated in adults with shift work disorder, with research focusing on
excessive sleepiness and objective measures of alertness during scheduled work periods.
Pharmacokinetics describes the movement of a medicine through the body and includes absorption,
distribution, metabolism, and elimination.
Researchers evaluate concentrations of modafinil in biological samples over time to determine how
systemic exposure changes.
Modafinil undergoes metabolic transformation, producing compounds that can be identified and
characterized through laboratory analysis.
The disappearance of the parent compound and its metabolites from the body is an important part
of pharmacokinetic modeling.
Pharmacodynamics examines the relationship between drug exposure and biological effects.
Researchers can compare drug concentrations with objective indicators of alertness and subjective
reports of sleepiness.
Pharmacological responses are not identical among all individuals. Differences in metabolism,
genetics, age, underlying conditions, and concurrent medications can contribute to variability.
The effects of modafinil have been examined in relation to several neurotransmitter networks
involved in arousal and attention.
Dopamine contributes to motivation, movement, attention, and arousal. Its transporter is one of
the best-characterized molecular targets associated with modafinil.
Norepinephrine participates in alertness, attention, and adaptive responses to environmental
stimuli.
Histaminergic neurons in the hypothalamus contribute to maintaining wakefulness and interact with
other arousal pathways.
Cholinergic signaling plays an important role in cortical activation, attention, and normal
wakefulness.
Modafinil has also been investigated experimentally in the context of cognitive performance.
Researchers have examined attention, working memory, and executive processes under controlled
conditions.
Long-duration attention tasks can help researchers determine how changes in alertness influence
performance and responsiveness.
Working memory allows information to be temporarily maintained and manipulated. Experimental
studies have evaluated whether altered arousal influences performance in this domain.
Research has also examined planning, cognitive flexibility, response inhibition, and other higher-
order processes. Results can vary depending on participant characteristics and experimental design.
Modern neuroimaging provides additional methods for examining pharmacological effects within the
human brain.
Functional imaging can identify changes in brain activity associated with attention, alertness,
and cognitive processing.
Molecular imaging techniques can be used to investigate interactions with transporters and other
components of neurotransmitter systems.
Safety is an essential component of the clinical evaluation of modafinil. Both common adverse
effects and rare serious reactions have been identified.
Reported adverse effects include headache, nausea, nervousness, dizziness, and insomnia.
Serious dermatological reactions have been reported and are specifically addressed in official
prescribing information.
Severe hypersensitivity reactions are uncommon but potentially serious and may involve multiple
organ systems.
Changes in mood, anxiety, agitation, and other psychiatric symptoms have also been reported and
form part of the overall safety assessment.
A medicine can affect another drug by changing its metabolism, absorption, concentration, or
pharmacological effect.
Modafinil influences certain cytochrome P450 enzyme pathways. This can alter the metabolism of
some concurrently administered medicines.
Official prescribing information warns that modafinil can reduce the effectiveness of certain
hormonal contraceptives.
A complete medication history is therefore important when healthcare professionals assess possible
interactions.
Analytical chemistry supports pharmaceutical development, quality control, and scientific research
involving modafinil.
Chromatographic methods can separate modafinil from related compounds, impurities, and degradation
products.
Mass spectrometry provides molecular information that can support identification of modafinil and
analysis of its metabolites.
Because modafinil contains stereoisomeric forms, analytical methods can be used to distinguish
between its enantiomers.
Reliable conclusions about a medicine depend on the quality of the evidence used to evaluate it.
Randomization helps distribute potentially confounding characteristics between study groups and
provides a structured basis for comparison.
Blinding can reduce the influence of expectations on participant responses and investigator
assessments.
Sleep research often combines subjective questionnaires with objective laboratory measurements to
produce a broader assessment of treatment effects.
Clinical trials provide important evidence, but monitoring continues after a medicine enters
routine clinical use.
Pharmacovigilance systems collect reports of suspected adverse reactions and evaluate potential
safety signals.
Rare adverse reactions can be difficult to identify in relatively small clinical trials and may
become more apparent when a medicine is used by larger populations.
Modafinil is regulated as a prescription medicine, and its legal classification depends on the
jurisdiction.
In the United States, modafinil is classified as a Schedule IV controlled substance.
U.S. prescribing information identifies narcolepsy, obstructive sleep apnea-associated excessive
sleepiness, and shift work disorder among its established clinical indications.
Regulatory classifications, approved uses, and prescribing requirements can differ between
countries.
Research on modafinil continues to contribute to broader investigations of sleep, alertness, and
neural communication.
Further work may clarify how dopamine, orexin, norepinephrine, histamine, and cholinergic systems
interact to stabilize wakefulness.
Future studies may help explain how genetic and metabolic differences contribute to variation in
pharmacological response.
A better understanding of excessive daytime sleepiness may support improved diagnostic approaches
and more precisely targeted therapies.
Modafinil is a prescription wakefulness-promoting medicine used in medical settings involving
certain disorders associated with excessive daytime sleepiness.
The dopamine transporter is one of the best-characterized molecular targets associated with
modafinil.
Yes. Armodafinil is the R-enantiomer of modafinil, while modafinil contains both R- and
S-enantiomeric forms.
No. Promoting wakefulness does not replace the physiological functions of adequate sleep.
Its principal clinical relevance is associated with disorders in which excessive daytime
sleepiness is a major symptom.
Yes. Modafinil has recognized adverse effects, clinically relevant drug interactions, and rare
but serious reactions that are described in official medical information.
Modafinil provides an important example of how pharmacology and sleep science intersect. Research
into the compound has helped scientists investigate dopamine transport, neural arousal, circadian
regulation, and the biological mechanisms underlying excessive daytime sleepiness.
Its scientific profile has been examined through clinical trials, pharmacokinetic studies,
neuroimaging, analytical chemistry, cognitive experiments, and long-term pharmacovigilance. Taken
together, these areas provide a multidimensional view of the medicine rather than reducing its
effects to a single neurotransmitter or mechanism.
Continued research into modafinil and related wakefulness-promoting medicines may provide further
insight into the complex relationship between sleep, circadian timing, neurotransmission, and
daytime alertness.
Curious if Our Approach Aligns with Your Needs?
Well Dawn Integrative Health, PLLC | Luke 6:31
My website was designed using 100% solar power
sign up
Sign up for our newsletter and never miss an update.
Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia • Texas: Dallas, Frisco, Plano, Denton, Arlington, Fort Worth, Houston, Austin, San Antonio • New Mexico: Albuquerque, Santa Fe, Las Cruces • Washington State: Seattle, Spokane, Vancouver, Tacoma, Olympia •